Breaking News Instant updates and real-time market news.

BAX

Baxter

$69.18

0.77 (1.13%)

09:08
01/08/18
01/08
09:08
01/08/18
09:08

Baxter announces amendments to pension plan

In a regulatory filing, Baxter said that on January 1, the Administrative Committee of the Compensation Committee of the Board of Directors approved an amendment to reorganize the Baxter International Inc. and Subsidiaries Pension Plan. Specifically, effective January 1, 2018, the amendment spun off the assets and liabilities of the U.S. Pension Plan attributable to current Company employees to a new Company plan. The assets and liabilities under the U.S. Pension Plan attributable to retired and former Company employees under the U.S. Pension Plan remained with that plan, after giving effect to the spin-off. The Active Plan, the Inactive Plan and the Baxter International Inc. and Subsidiaries Supplemental Pension Plan were further amended on January 5, 2018 to cease the accruals of additional benefits thereunder effective December 31, 2022. As a result, years of additional service earned and eligible compensation received after December 31, 2022 will not be included in the determination of the benefits payable under the Active Plan, the Inactive Plan or the Supplemental Pension Plan. There are no anticipated changes to the benefits eligible to be earned under any plan until January 1, 2023. The Inactive Plan and the Supplemental Pension Plan were further amended on January 5, 2018 to provide transition benefits for a limited number of former Company employees who are accruing disability pension benefits on January 5, 2018 and will not yet be 65 years of age on December 31, 2022. Those individuals will be credited with the service through age 65 that they would have received had the Freeze not occurred for purposes of determining their pension benefits. The Company's obligations under the U.S. Pension Plan and the Supplemental Pension Plan represented approximately 40% of the Company's long-term financial obligations (excluding the fair value of net assets already contributed to the plans) as of September 30, 2017 and constituted the Company's largest financial obligation as of that date. After giving effect to contributions of $115 million to the U.S. Pension Plan in the fourth quarter of 2017 and the Freeze, the Company expects that the U.S. Pension Plan was nearly fully funded as of December 31, 2017. The Company has decided to make these changes, consistent with actions previously taken by many Company peers, in the interest of minimizing the financial impact of changes in the value of the Company's pension investments. Estimated impacts of these actions will be included in the Company's 2018 financial guidance, to be provided on the Company's fourth quarter 2017 earnings call on February 1, 2018.

  • 08

    Jan

  • 26

    Feb

BAX Baxter
$69.18

0.77 (1.13%)

01/02/18
BOFA
01/02/18
UPGRADE
Target $73
BOFA
Buy
Baxter upgraded to Buy at BofA/Merrill
As previously reported, BofA/Merrill upgraded Baxter to Buy from Neutral and increased its price target to $73 from $64. Analyst Bob Hopkins expects Baxter to put its $7B balance sheet liquidity to work through M&A and buybacks, which should set the stage for improving revenue growth in 2019-20.
01/02/18
01/02/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. L Brands (LB) upgraded to Outperform from Neutral at Baird with analyst Mark Altschwagern saying he believes the company is on track to meet or exceed December comparable sales and fourth quarter expectations. 2. Lennar (LEN) upgraded to Outperform from Market Perform at Wells Fargo with analyst Stephen East citing his post-tax reform earnings per share estimate but without the CalAtlantic (CAA) acquisition included. 3. Disney (DIS), Netflix (NFLX), AMC Networks (AMCX), and Discovery (DISCA) were upgraded to Outperform from Neutral at Macquarie. 4. Abbott (ABT) was upgraded to Overweight from Equal Weight at Morgan Stanley and to Overweight from Neutral at JPMorgan. 5. Baxter (BAX) was upgraded to Buy from Neutral at BofA/Merrill and to Overweight from Neutral at JPMorgan. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
01/03/18
RAJA
01/03/18
UPGRADE
Target $73
RAJA
Outperform
Baxter upgraded to Outperform, view as a core holding at Raymond James
Raymond James analyst Lawrence Keusch upgraded Baxter to Outperform from Market Perform and established a $73 price target saying he views it as a core holding. Keusch has high confidence in management execution, an emerging new product portfolio, and balance sheet optionality. He sees organic cc revenue growth in the 4% range driven by geographic expansion after recent underperformance in Europe, as well as continued growth in Asia. Further, after a period of underinvestment, the R&D pipeline as been revitalized and should begin to accelerate growth in 2019 and beyond. Finally, the analyst said Baxter has considerable balance sheet flexibility with $7-$8B available for bolt-on acquisitions.
01/03/18
EVER
01/03/18
INITIATION
Target $71
EVER
Outperform
Baxter initiated with an Outperform at Evercore ISI
Evercore ISI analyst Vijay Kumar started Baxter with an Outperform rating and $71 price target. The analyst thinks Baxter should be able to meet or beat 2018 Street expectations and its balance sheet strength gives it over $10B in capacity for M&A, he tells investors.

TODAY'S FREE FLY STORIES

ZSAN

Zosano Pharma

$0.47

0.0164 (3.64%)

10:55
01/23/18
01/23
10:55
01/23/18
10:55
Conference/Events
Zosano Pharma to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

OSTK

Overstock.com

$77.40

-0.25 (-0.32%)

10:50
01/23/18
01/23
10:50
01/23/18
10:50
Periodicals
Overstock ICO promotion 'false and misleading,' Medium contributor says »

A contributor to Medium…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTRP

Ctrip.com

$46.14

-0.71 (-1.52%)

10:50
01/23/18
01/23
10:50
01/23/18
10:50
Options
Short-term put buyers in Ctrip as shares stumble »

Short-term put buyers in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OBLN

Obalon Therapeutics

$5.19

-0.05 (-0.95%)

10:46
01/23/18
01/23
10:46
01/23/18
10:46
Hot Stocks
Obalon Therapeutics terminates stock offering after whistleblower allegations »

Obalon Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

TFX

Teleflex

$274.20

-0.55 (-0.20%)

10:44
01/23/18
01/23
10:44
01/23/18
10:44
Conference/Events
Leerink medical devices analysts hold an analyst/industry conference call »

Medical Devices Analysts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jan

  • 28

    Feb

  • 01

    Mar

TWTR

Twitter

$22.73

-0.5928 (-2.54%)

10:42
01/23/18
01/23
10:42
01/23/18
10:42
Recommendations
Twitter analyst commentary  »

Twitter data points to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 07

    Feb

  • 08

    Feb

  • 28

    Feb

ILG

ILG

$29.45

-0.03 (-0.10%)

10:40
01/23/18
01/23
10:40
01/23/18
10:40
Options
Repeat interest in ILG Mar 30 calls »

Repeat interest in ILG…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:35
01/23/18
01/23
10:35
01/23/18
10:35
Conference/Events
Morgan Stanley technology analyst holds an analyst/industry conference call »

Technology/Hardware…

ABEO

Abeona Therapeutics

$14.85

0.25 (1.71%)

, JKHY

Jack Henry

$125.32

0.17 (0.14%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

ABEO

Abeona Therapeutics

$14.85

0.25 (1.71%)

JKHY

Jack Henry

$125.32

0.17 (0.14%)

WWD

Woodward

$81.02

0.52 (0.65%)

NAV

Navistar

$44.96

0.21 (0.47%)

GBT

Global Blood Therapeutics

$56.35

2.4 (4.45%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 24

    Jan

  • 24

    Jan

NFLX

Netflix

$227.58

7.12 (3.23%)

, GPRO

GoPro

$6.30

0.01 (0.16%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

NFLX

Netflix

$227.58

7.12 (3.23%)

GPRO

GoPro

$6.30

0.01 (0.16%)

W

Wayfair

$88.60

-2.04 (-2.25%)

FTNT

Fortinet

$45.85

-0.16 (-0.35%)

S

Sprint

$5.23

-0.091 (-1.71%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 01

    Feb

  • 02

    Feb

  • 05

    Feb

  • 22

    Feb

DG

Dollar General

$103.69

1.424 (1.39%)

, DKS

Dick's Sporting

$34.91

0.29 (0.84%)

10:31
01/23/18
01/23
10:31
01/23/18
10:31
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

DG

Dollar General

$103.69

1.424 (1.39%)

DKS

Dick's Sporting

$34.91

0.29 (0.84%)

CAT

Caterpillar

$170.43

-0.46 (-0.27%)

RMD

ResMed

$101.77

14.26 (16.30%)

HPE

HP Enterprise

$16.37

0.315 (1.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 01

    Feb

SBUX

Starbucks

$61.41

0.15 (0.24%)

10:30
01/23/18
01/23
10:30
01/23/18
10:30
Options
Starbucks calls drawing interest ahead of earnings »

Starbucks calls drawing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

KMB

Kimberly-Clark

$117.35

0.4358 (0.37%)

10:29
01/23/18
01/23
10:29
01/23/18
10:29
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

KMI

Kinder Morgan

$19.45

-0.18 (-0.92%)

10:28
01/23/18
01/23
10:28
01/23/18
10:28
Hot Stocks
Kinder Morgan begins operations of Utopia Pipeline system »

Kinder Morgan announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMB

Kimberly-Clark

$117.26

0.35 (0.30%)

10:27
01/23/18
01/23
10:27
01/23/18
10:27
Hot Stocks
Breaking Hot Stocks news story on Kimberly-Clark »

Kimberly-Clark: China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

PFIE

Profire Energy

$2.01

0.03 (1.52%)

10:26
01/23/18
01/23
10:26
01/23/18
10:26
Conference/Events
Profire Energy management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

NFLX

Netflix

$227.58

7.12 (3.23%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Netflix management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

MLHR

Herman Miller

$40.95

0.4 (0.99%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Herman Miller management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 30

    Jan

  • 31

    Jan

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
RBC Capital software analysts hold an analyst/industry conference call »

Software Analysts…

RARE

Ultragenyx

$53.39

4.23 (8.60%)

10:25
01/23/18
01/23
10:25
01/23/18
10:25
Conference/Events
Ultragenyx participates in a conference call with JPMorgan »

Investor conference call…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 17

    Apr

  • 24

    Jan

LLEX

Lilis Energy

$4.86

-0.14 (-2.80%)

10:24
01/23/18
01/23
10:24
01/23/18
10:24
Conference/Events
Lilis Energy management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 31

    Jan

EBAY

eBay

$39.58

1.15 (2.99%)

, GOOG

Alphabet

$1,155.81

18.3 (1.61%)

10:21
01/23/18
01/23
10:21
01/23/18
10:21
Periodicals
eBay CEO says shoppers are shifting to voice technology, CNBC reports »

eBay (EBAY) CEO Devin…

EBAY

eBay

$39.58

1.15 (2.99%)

GOOG

Alphabet

$1,155.81

18.3 (1.61%)

GOOGL

Alphabet Class A

$1,164.16

20.66 (1.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 01

    Feb

  • 01

    Feb

  • 07

    Feb

  • 28

    Feb

  • 18

    Mar

CMD

Cantel Medical

$112.00

0.7 (0.63%)

10:21
01/23/18
01/23
10:21
01/23/18
10:21
Conference/Events
Cantel Medical management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

  • 31

    Jan

KMB

Kimberly-Clark

$116.87

-0.04 (-0.03%)

10:20
01/23/18
01/23
10:20
01/23/18
10:20
Hot Stocks
Kimberly-Clark sees 2H18 EPS higher than 1H18 »

On its Q4 earnings call,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

10:20
01/23/18
01/23
10:20
01/23/18
10:20
General news
Nasdaq leads major averages as Netflix jumps after earnings »

Stock futures were little…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.